Hémovigilance à Tunis (hôpital La Rabta) : bilan 2007–2013

Mahjoub, S.; Baccouche, Héla; Raissi, A.; Hamed, L. Ben; Romdhane, N. Ben

doi:10.1016/j.tracli.2015.12.010

Cited by 4 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These data are 1.5 times lower than previously observed in our country [9] and 10 to 100 times higher than those reported in Morocco (0.0025 to 0.02 per 1,000 units) and South Africa (0.03/1,000 units) [7, 19, 22]. The incidence was approximately the same as in Tunisia (0.24/1,000 units) [20].…”

Section: Discussioncontrasting

confidence: 43%

“…Adverse reactions ratio was 7 times lower in our study than in the pilot phase (2.1 versus 16.1 cases per 1,000 units). In Morocco and Tunisia, the ratio varied from 0.5 to 1.6/1,000 [7, 19] and from 0.59 to 2.19/1,000 blood units [20], respectively. In Namibian, Zimbabwean, and South African systems, these ratios were, respectively, 0.8, 0.46, and 0.82 per 1,000 blood units [18, 21, 22].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso

Sawadogo

Nébié

Millogo³

et al. 2018

Advances in Hematology

View full text Add to dashboard Cite

Traceability is an essential tool for haemovigilance and transfusion safety. In Burkina Faso, the implementation of haemovigilance has been achieved as part of a pilot project from 2005 to 2009. Our study aims to evaluate the traceability of blood transfusions and reporting of adverse reactions over the 6-year postpilot phase. A cross-sectional study including all blood units ordered between 2010 and 2015 has been conducted in public and private health care facilities supplied with blood products by the transfusion center of Bobo-Dioulasso. The complete traceability was possible for 83.5% of blood units delivered. Adverse reactions were reported in 107 cases representing 2.1/1,000 blood units per annum. Transfusions of wrong blood to wrong patient were reported in 13 cases. Our study shows that the haemovigilance system in Burkina Faso must be improved. Healthcare workers have to be sensitized on how traceability and haemovigilance could impact the quality of care provided to patients.

show abstract

Section: Discussioncontrasting

confidence: 43%

Section: Discussionmentioning

confidence: 99%

Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso

Sawadogo

Nébié

Millogo³

et al. 2018

Advances in Hematology

View full text Add to dashboard Cite

show abstract

Transfusion-associated graft-versus-host disease, transfusion-associated hyperkalemia, and potassium filtration: advancing safety and sufficiency of the blood supply

Nollet¹,

Ngoma²,

Ohto³

2022

Transfusion and Apheresis Science

View full text Add to dashboard Cite

Bacterial contamination of blood products in Africa

et al. 2021

View full text Add to dashboard Cite

Background: Bacterial contamination of blood components (notably platelets) remains a leading infectious risk to the blood supply. There has been extensive research in high-income countries to characterize the risk of bacterial contamination along with adoption of strategies to mitigate that risk. By contrast, related data in Africa are lacking. Study Design and Methods: An electronic survey was distributed to members of African Society of Blood Transfusion to assess existing or planned measures at African blood centers and hospitals to mitigate bacterial contamination of blood products. A literature review of studies pertaining to related transfusion-associated risk in Africa was conducted to complement the findings. Results: Forty-five responses were received, representing 16 African countries. All respondents were urban, either in blood centers (n = 36) or hospital-based transfusion services (n = 9). Reported measures included skin disinfection (n = 41 [91.1%]); diversion pouches (n = 14 [31.1%]); bacterial culture (n = 9 [20%]); pathogen reduction (PR) (n = 3 [6.7%]); and point-of-release testing (PoRT) (n = 2 [4.4%]). Measures being considered for implementation included: skin disinfection (n = 2 [4.4%]); diversion pouches (n = 2 [4.4%]); bacterial culture n = 14 (31.1%); PR (n = 11 [24.4%]); and PoRT (n = 4 [8.9%]). Of the 38 respondents who reported collection of platelets, 14 (36.8%) and 8 (21.1%) reported using diversion pouches and bacterial culture, respectively. The literature review identified 36 studies on the epidemiology of bacterial contamination and septic transfusion reactions in Africa; rates of contamination ranged from 0% to 17.9%. Conclusions: The findings suggest that prevention of bacterial contamination of blood components and transfusion-associated sepsis in Africa remains neglected. Regional preventive measures have not been widely adopted. 1 | INTRODUCTION Bacterial contamination of blood products-notably platelets-remains a leading transfusion-associated risk, even in high-resource settings. 1 In the United States (US), bacterial contamination is the second most common cause of reported transfusion-related death (after transfusion-associated circulatory overload), 2 and

show abstract

Hémovigilance à Tunis (hôpital La Rabta) : bilan 2007–2013

Cited by 4 publications

References 30 publications

Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso

Traceability of Blood Transfusions and Reporting of Adverse Reactions in Developing Countries: A Six-Year Postpilot Phase Experience in Burkina Faso

Transfusion-associated graft-versus-host disease, transfusion-associated hyperkalemia, and potassium filtration: advancing safety and sufficiency of the blood supply

Bacterial contamination of blood products in Africa

Contact Info

Product

Resources

About